• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Comput Biol . Use of compressed sensing to expedite high-throughput diagnostic testing for COVID-19 and beyond

tetano

Editor, Senior Moderator
PLoS Comput Biol


. 2022 Oct 24;18(10):e1010629.
doi: 10.1371/journal.pcbi.1010629. Online ahead of print.
Use of compressed sensing to expedite high-throughput diagnostic testing for COVID-19 and beyond


Kody A Waldstein[SUP] 1 [/SUP], Jirong Yi[SUP] 2 [/SUP], Myung Cho[SUP] 3 [/SUP], Raghu Mudumbai[SUP] 2 [/SUP], Xiaodong Wu[SUP] 2 [/SUP], Steven M Varga[SUP] 1 4 5 [/SUP], Weiyu Xu[SUP] 2 [/SUP]



Affiliations

Abstract

The rapid spread of SARS-CoV-2 has placed a significant burden on public health systems to provide swift and accurate diagnostic testing highlighting the critical need for innovative testing approaches for future pandemics. In this study, we present a novel sample pooling procedure based on compressed sensing theory to accurately identify virally infected patients at high prevalence rates utilizing an innovative viral RNA extraction process to minimize sample dilution. At prevalence rates ranging from 0-14.3%, the number of tests required to identify the infection status of all patients was reduced by 69.26% as compared to conventional testing in primary human SARS-CoV-2 nasopharyngeal swabs and a coronavirus model system. Our method provided quantification of individual sample viral load within a pool as well as a binary positive-negative result. Additionally, our modified pooling and RNA extraction process minimized sample dilution which remained constant as pool sizes increased. Compressed sensing can be adapted to a wide variety of diagnostic testing applications to increase throughput for routine laboratory testing as well as a means to increase testing capacity to combat future pandemics.
 
Back
Top Bottom